Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2003
08/13/2003CN1435180A Gypenoside drip pill, and preparing process thereof
08/13/2003CN1435178A Osmosis pump controlled release preparation contg. Chinese medicine of cyclovirobuxine D, and preparing method thereof
08/13/2003CN1435176A Triclabendazole-contg. preparation based on surfactant
08/13/2003CN1435174A Externally used urotropin nebula and preparing method thereof
08/13/2003CN1435173A Medicinal desensitization nanopatch contg. far infrared matter
08/13/2003CN1435172A Method for preparing coarse powder of root and rhizome Chinese medicinal materials
08/13/2003CN1435171A Method for preparing coarse powder of fruit and seed Chinese medicinal materials
08/13/2003CN1435170A Method for preparing coarse powder of bark Chinese medicinal material
08/13/2003CN1435169A Method for preparing coarse powder of vine chinese medicinal material
08/13/2003CN1435168A Serial Chinese traditional medicine nanopreparation
08/13/2003CN1435167A Carboplatin precursor liposome injection and preparing process thereof
08/13/2003CN1435121A Heat-clearing factor
08/13/2003CN1117829C Gel-form pressure-sensitive adhesive, and adhesive material and adhisive medicinal preparation both contg. same
08/13/2003CN1117762C Spray dried erythropoietin
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/13/2003CN1117582C medicine for treating rheumatoid arthritis and preparing process thereof
08/13/2003CN1117580C Ointment for treating bone fracture and injury
08/13/2003CN1117579C Plaster for treating common cold
08/13/2003CN1117578C Plaster for treating hyperosteogeny
08/13/2003CN1117577C Plaster for treating periomethritis
08/13/2003CN1117571C Improved calcium dietary supplement
08/13/2003CN1117570C Ointment for external use
08/13/2003CN1117567C Paroxetine controlled release compositions
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/13/2003CN1117565C Stable anti-racemic medicinal preparation of cilancetlone
08/13/2003CN1117562C Compositions and method for controlling smoking
08/12/2003US6605751 Silver-containing compositions, devices and methods for making
08/12/2003US6605722 Tyrosine derivatives with anti-leukotrienen activity
08/12/2003US6605666 Polyurethane film-forming dispersions in alcohol-water system
08/12/2003US6605609 N-(((5S)-3-(4-(1,1-dioxido-4-thiomorpholinyl)-3,5-difluorophen yl) -2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide antimicrobial used in combination therapy
08/12/2003US6605597 Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
08/12/2003US6605594 Aqueous glycerol formulations of somatotropin
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605310 Calorically dense liquid oral supplement
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/12/2003US6605302 Drug delivery device containing oseltamivir and an H1 antagonist
08/12/2003US6605301 Dispersible macrolide compounds and method for production thereof
08/12/2003US6605300 Oral pulsed dose drug delivery system
08/12/2003US6605299 Releasable linkage and compositions containing same
08/12/2003US6605298 Drug delivery
08/12/2003US6605295 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
08/12/2003US6605294 Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
08/12/2003US6605291 Containing spinels
08/12/2003US6605255 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body
08/12/2003US6604698 Forming a dispersion of solid particles of a milled substrate in a fluid carrier comprising providing large size milling media and small size milling media, a conglomerate of solid comprising a substrate to be milled, milling, separating
08/12/2003CA2378713C Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments
08/12/2003CA2296373C Composition and method for treating penile erectile dysfunction
08/12/2003CA2286126C Pharmaceutical compositions
08/07/2003WO2003065392A2 Photovoltaic cell interconnection
08/07/2003WO2003064993A2 Methods and materials for detecting genetic material
08/07/2003WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003WO2003064607A2 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
08/07/2003WO2003064515A1 Device and method for producing a cross-linked substance, especially in the form of a microcapsule or layer
08/07/2003WO2003064514A1 Device and method for producing microcapsules and improved microcapsule
08/07/2003WO2003064459A1 Peptides for increasing transfection efficiency
08/07/2003WO2003064449A2 Bioactive keratin peptides
08/07/2003WO2003064409A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003WO2003064398A1 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
08/07/2003WO2003063911A1 Decoy-containing pharmaceutical compositions and method of using the same
08/07/2003WO2003063910A2 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER
08/07/2003WO2003063909A1 Responsive microgel and methods related thereto
08/07/2003WO2003063877A1 Cefquinome composition for intra-mammary administration in cattle
08/07/2003WO2003063868A1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
08/07/2003WO2003063867A1 Stable saccharide-free tablets comprising a salt of quinapril or moexipril
08/07/2003WO2003063856A1 Jelly preparation containing branched amino acids
08/07/2003WO2003063855A1 Chewable tablet containing branched amino acids
08/07/2003WO2003063854A1 Chewable tablet containing branched amino acids
08/07/2003WO2003063843A1 Composition for inhalation
08/07/2003WO2003063842A1 Composition for inhalation
08/07/2003WO2003063841A1 Cyclosporin-containing sustained release pharmaceutical composition
08/07/2003WO2003063840A2 Transmucosal delivery of proton pump inhibitors
08/07/2003WO2003063839A1 Bioadhesive composition comprising a polysaccharide and a polycarboxylated polymer
08/07/2003WO2003063838A1 Dry granulated formulations of azithromycin
08/07/2003WO2003063837A1 Increased-dosage nelfinavir tablet and method of making same
08/07/2003WO2003063836A1 Stable pharmaceutical composition comprising pravastatin sodium
08/07/2003WO2003063835A1 Composition comprising low water soluble compounds within porous carriers
08/07/2003WO2003063834A1 Multi-stage oral drug controlled-release system
08/07/2003WO2003063833A1 Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
08/07/2003WO2003063832A1 Pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors
08/07/2003WO2003063831A2 Immediate release dosage forms containing solid drug dispersions
08/07/2003WO2003063830A1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use
08/07/2003WO2003063829A1 Medicated tampon
08/07/2003WO2003063828A1 Jojoba product for reducing weight, blood lipid levels and for the prevention and treatment of cancer
08/07/2003WO2003063826A2 Ophthalmic compositions including oil-in-water emulsions, and methods for making and using the same
08/07/2003WO2003063825A1 Pharmaceutical composition for extended/sustained release of therapeutically active ingredient
08/07/2003WO2003063824A2 Pharmaceutical composition
08/07/2003WO2003063823A2 Osmotic delivery system
08/07/2003WO2003063822A2 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
08/07/2003WO2003063821A2 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
08/07/2003WO2003063820A2 Demixing-stable granulate
08/07/2003WO2003063799A2 Compositions and methods for systemic inhibition of cartilage degradation
08/07/2003WO2003063786A2 Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
08/07/2003WO2003063785A2 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
08/07/2003WO2003063772A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003WO2003063617A1 Isotropic transparent compositions containing fat soluble vitamin
08/07/2003WO2003063616A1 Use of multi-layer pigments in the food and pharmaceutical industry
08/07/2003WO2003063604A1 Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
08/07/2003WO2003063603A1 Hard sugar coated preparations, sugar coating solutions and process for producing hard sugar coated preparation
08/07/2003WO2003063573A2 Method for treating diseases with omega interferon
08/07/2003WO2003035002B1 Management of postoperative pain
1 ... 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 ... 2991